TrialClinical drug investigation2021

Single-Dose Pharmacokinetics, Pharmacodynamics and Immunogenicity, and Multiple-Dose Immunogenicity of INTP5 (Pegfilgrastim Biosimilar) Versus Reference Pegfilgrastim in Healthy Subjects.

Inderjeet Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.